SCHEMBL791121

SCHEMBL791121

CCS(=O)(=O)c1ccc(-c2cc3cc(Cl)ccc3nc2N)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.46
RORC P51449 1/20 0.43
JAK2 O60674 1/20 0.42
CYP1A2 P05177 6/20 0.42
CYP3A4 P08684 6/20 0.42
CYP2C9 P11712 6/20 0.42
CYP2D6 P10635 4/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
MAP4K4 O95819 1/20 0.41
CYP2C19 P33261 5/20 0.40
CHRNA7 P36544 1/20 0.40
GAA P10253 1/20 0.40
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
SCD O00767 1/20 0.38
KCNH2 Q12809 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL790083 0.85 PTGS2 (0.51) MEN1NPC1RAB9AKMT2ACHRNA7
SCHEMBL807030 0.80 MEN1 (0.39) MEN1NPC1RAB9AKMT2AMAP4K4
SCHEMBL791451 0.76 MKNK1 (0.42) JAK2CYP1A2CYP3A4CYP2C9MAP4K4
SCHEMBL807329 0.73 SCN10A (0.48) MEN1NPC1RAB9AKMT2AMAP4K4
SCHEMBL807332 0.72 DHFR (0.37) MEN1NPC1RAB9AKMT2AMAP4K4
SCHEMBL789599 0.72 PI4KA (0.52) MAP4K4KCNH2
SCHEMBL789814 0.72 PIK3CG (0.53)
SCHEMBL10277282 0.72 PIK3CG (0.48) RORCKCNH2
SCHEMBL16192761 0.72 PTGDR2 (0.58) PTGDR2RORCGAAPTGS1PTGS2
SCHEMBL796868 0.71 PIK3CG (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed
WO-2012037108-A1 AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed